Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography.
about
Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administrationSilodosin for benign prostatic hyperplasia.The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia.Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasiaPhysiological and pharmacological aspects of the vas deferens-an updateMeasurement of benign prostatic hyperplasia treatment effects on male sexual function.Update on the sexual impact of treatment for benign prostatic hyperplasia.Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function.Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment.Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study).Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil.The role of sympathetic and parasympathetic nerve systems on the smooth muscle of rat seminal vesicles - experimental results and speculation for physiological implication on ejaculation.Comparison of Two Different α1-Adrenoceptor Antagonists, Tamsulosin and Silodosin, in the Treatment of Male Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Prospective Randomized Crossover Study.Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
P2860
Q24632336-4D10514C-A6C6-4D51-B977-10AB9650ECD1Q33158241-65A62B1E-687C-4968-8614-56C5BDCD7D84Q33650768-1A630794-E60B-47A6-9123-6D92EBF0FEA6Q34452517-D36EAE5D-1EAC-47D4-ADC7-CB836B0C95FCQ37111681-1A1D50EE-237E-4ADA-9013-5C577309969FQ37523227-0C31B2CE-CE54-4A03-86A7-0DBBE932E6FAQ38052091-69A00E73-FB50-48DE-A24A-32E140E374BFQ38081486-F11A1333-7ADB-485A-84E0-E1DC08F98B0AQ38239520-1FFB555B-8509-416B-802D-F946045CFDD7Q38396192-232884C8-8F57-4258-9281-37E69262C70BQ39926524-BE6FC9DC-C135-481D-9A90-2BEFC0225200Q45052984-67F0704A-AB11-4BCA-9120-CB00F360C7EFQ46379347-7CA2F055-99F8-402D-AFF1-CE7BA0820C31Q53138322-41B7A58C-6D34-4128-B2B5-A1B1C95F57C2Q53160010-F89637F8-A29D-4540-8C54-0A457EFDD12A
P2860
Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@ast
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@en
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@nl
type
label
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@ast
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@en
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@nl
prefLabel
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@ast
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@en
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@nl
P2093
P2860
P1476
Ejaculatory dysfunction caused ...... color Doppler ultrasonography.
@en
P2093
Atsushi Nagai
Ryoei Hara
Teruhiko Yokoyama
Tomohiro Fujii
Yoshimasa Jo
Yoshiyuki Miyaji
P2860
P304
P356
10.1111/J.1442-2042.2008.02136.X
P577
2008-10-01T00:00:00Z